By PPN News Staff
IMI - International Medical Industries Inc. joined DoseID, the first member-driven industry consortium to expand the interoperability of radiofrequency identification (RFID) technology in the health care space.
DoseID consists of industry innovators who are committed to increasing the interoperability, quality and performance of RFID-tagged products as they move through the pharmaceutical supply chain from manufacturer to patient.